Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00034914.xml
Download PDF
Osteologie 2025; 34(02): 160-162
DOI: 10.1055/a-2535-2686
DOI: 10.1055/a-2535-2686
Osteoporose-Update
Osteoporose Update
Das Osteoporose Update 2024 ging auf relevante, aktuelle, d. h. mit Fokus auf in den letzten 6 Monaten publizierte Paper ein, die in Zusammenhang mit Empfehlungen der Leitlinie gestellt werden.
Publication History
Article published online:
16 May 2025
© 2025. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
Literatur
- 1 Thomasius F, Kurth A, Baum E, Drey M, Maus U, Schmidmaier R. Clinical practice guideline: The diagnosis and treatment of osteoporosis. Dtsch Arztebl Int 2025; 122: 12-18
- 2 Black DM, Cummings SR, Karpf DB. et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 1996; 348: 1535-4
- 3 Harris ST, Watts NB, Genant HK. et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral efficacy with risedronate therapy (VERT) study group. JAMA 1999; 282: 1344-1352
- 4 Chesnut CH, Skag A, Christiansen C. et al. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res 2004; 19: 1241-1249
- 5 Black DM, Delmas PD, Eastell R. et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 2007; 356: 1809-1822
- 6 Cummings SR, San Martin J, McClung MR. et al. FREEDOM Trial. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 2009; 361: 756-765
- 7 Ettinger B, Black DM, Mitlak BH. et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. Results from a 3-year randomized clinical trial. JAMA 1999; 282: 637-645
- 8 Neer RM, Arnaud CD, Zanchetta JR. et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001; 344: 1434-1441
- 9 Cosman F, Crittenden DB, Adachi JD. et al. Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med 2016; 375: 1532-1543
- 10 ISCD (2019) 2019 ISCD Official Positions – Adult https://iscd.org/wp-content/uploads/2021/09/2019-Official-Positions-Adult-1.pdf